Bibliographie sur le cannabis

Bibliographie sur le cannabis, Xperimentations.ca Bibliographie sur le cannabis Aldington, S., M. Williams, M. Nowitz, M. Weatherall, A. Pritchard, ...
Author: Lee Stevenson
3 downloads 0 Views 569KB Size
Bibliographie sur le cannabis, Xperimentations.ca

Bibliographie sur le cannabis Aldington, S., M. Williams, M. Nowitz, M. Weatherall, A. Pritchard, A. McNaughton et coll. The effects of cannabis on pulmonary structure, function and symptoms, Thorax, vol. 62(12), 2007, p. 1058–1063. Aldington, S., M. Harwood, B. Cox, M. Weatherall, L. Beckert, A. Hansell et coll. Cannabis use and risk of lung cancer: A case-control study, European Respiratory Journal, vol. 31, 2008, p. 280–286. Arseneault, L., M. Cannon, R. Poulton, R. Murray, A. Caspi et T.E. Moffitt. Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study, British Medical Journal, vol. 325, 2002, p. 1212–1213. Ashton, C.H. Pharmacology and effects of cannabis: A brief review, British Journal of Psychiatry, vol. 178, 2001, p. 101–106. Barsky, S., M. Roth, E. Kleerup, M. Simmons et D. Tashkin. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine or tobacco, Journal of the National Cancer Institute, vol. 90, 1998, p. 1198–1204. Battisti, R.A., S. Roodenrys, S.J. Johnstone, C. Respondek, D.F. Hermens et N. Solowij. Chronic use of cannabis and poor neural efficiency in verbal memory ability, Psychopharmacology, vol. 209, 2010, p. 319–330. Berghaus, G. et B.L. Guo. Medicines and driver fitness: Findings from a meta-analysis of experimental studies as basic information to patients, physicians and experts. Dans C.N. Dloeden et A.J. McLean (éd.), Alcohol, Drugs and Traffic Safety, T’95: Proceedings of the 13th International Conference on Alcohol, Drugs and Traffic Safety, Adelaïde (p. 295–300), 1995. Berthiller, J., K. Straif, M. Boniol, N. Voirin, V. Benhaim-Luzon, W.B. Ayoub et coll. Cannabis smoking and risk of lung cancer in men: A pooled analysis of three studies in Maghreb, Journal of Thoracic Oncology, vol. 3, 2008, p. 1398–1403. Bifulco, M., C. Laezza, S. Pisanti et P. Gazzerro. Cannabinoids and cancer: Pros and cons of an antitumour strategy, British Journal of Pharmacology, vol. 148, 2006, p. 123–135. Bolla, K.I., D.A. Eldreth, J.A. Matochik et J.L. Cadet. Neural substrates of faulty decisionmaking in abstinent marijuana users, NeuroImage, vol. 26, 2005, p. 480–492. Budney, A.J., J.R. Hughes, B.A. Moore et R.G. Vandrey. A review of the validity and significance of the cannabis withdrawal syndrome, American Journal of Psychiatry, vol. 161, 2004, p. 1967–1977.

© Centre canadien de lutte contre l’alcoolisme et les toxicomanies | Janvier 2011

Page 2 de 10

Bibliographie sur le cannabis, Xperimentations.ca

Budney, A.J., B.A. Moore, R.G. Vandrey et J.R. Hughes. The time course and significance of cannabis withdrawal, Journal of Abnormal Psychology, vol. 112, 2003, p. 393–402. Burns, M. Medical-legal aspects of drugs (2nd ed.), Tucson (AZ), Lawyers & Judges Publishing Company, 2007. Busch, F., D. Seid et E. Wei. Mutagenic activity of marihuana smoke condensates, Cancer Letters, vol. 6, 1979, p. 319–324. Cherek, D.R., S.D. Lane et D.M. Dougherty. Possible amotivational effects following marijuana smoking under laboratory conditions, Experimental and Clinical Psychopharmacology, vol. 10(1), 2002, p. 26–38. Cheung, J.T.W., R.E. Mann, A. Ialomiteanu, G. Stoduto, V. Chan, K. Ala-Leppilampi et coll. Anxiety and mood disorders and cannabis use, American Journal of Drug and Alcohol Abuse, vol. 36, 2010, p. 118–122. Copersino, M.L., S.J. Boyd, D.P. Tashkin, M.A. Huestis, S.J. Heishman, J.C. Dermand et coll. Cannabis withdrawal among non-treatment-seeking adult cannabis users, American Journal of Addiction, vol. 15, 2006, p. 8–14. Crowley, T.J., M.J. Macdonald, E.A. Whitmore et S.K. Mikulich. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders, Drug and Alcohol Dependence, vol. 50, 1998, p. 27–37. Dawes, M.A., A. Liguori et D.M. Dougherty. Cannabis withdrawal among adolescent cannabis users in an outpatient research setting, American Journal of Addiction, vol. 15, 2006, p. 485–486. Day, N.L., L. Goldschmidt et C.A. Thomas. Prenatal marijuana exposure contributes to the prediction of marijuana use at age 14, Addiction, vol. 101, 2006, p. 1313–1322. Day, N.L., G.A. Richardson, L. Goldschmidt, N. Robles, P.M. Taylor, D.S. Stoffer et coll. Effect of prenatal marijuana exposure on the cognitive development of offspring at age three, Neurotoxicology and Teratology, vol. 16, 1994, p. 169–175. Degenhardt, L., C. Tennant, S. Gilmour, D. Schofield, L. Nash, W. Hall et coll. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: Findings from a 10-month prospective study, Psychological Medicine, vol. 37, 2007, p. 927–934. de Graaf, R., M. Radovanovic, M. van Laar, B. Fairman, L. Degenhardt, S. Aguilar-Gaxiola et coll. Early cannabis use and estimated risk of later onset of depression spells: Epidemiologic evidence from the population-based World Health Organization World Mental Health Survey Initiative, American Journal of Epidemiology, vol. 172, 2010, p. 149–159.

© Centre canadien de lutte contre l’alcoolisme et les toxicomanies | Janvier 2011

Page 3 de 10

Bibliographie sur le cannabis, Xperimentations.ca

Denissenko, M., A. Pao, M.S. Tang et G. Pfeifer. Preferential formation of benzo[α]pyrene adducts at lung cancer mutational hotspots in p53, Science, vol. 274, 1996, p. 430. Dott, A.B. Effect of marijuana on risk acceptance in a simulated passing task (Public Health Service Report ICRL-RR-71-3, DHEW Publication No. HSM-72-10010), Washington (DC), U.S. Government Printing Office, 1972. Ehrenreich, H., T. Rinn, H.J. Kunert, M.R. Moeller, W. Poser, L. Schilling et coll. Specific attentional dysfunction in adults following early start of cannabis use, Psychopharmacology, vol. 142, 1999, p. 295–301. Fligiel, S., M. Roth, E. Kleerup, S. Barsky, M. Simmons et D. Tashkin. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco, Chest, vol. 112, 1997, p. 319–326. Fried, P.A. et B. Watkinson. 36- and 48-month neurobehavioural follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol, Journal of Developmental and Behavioural Pediatrics, vol. 11, 1990, p. 49–58. Fried, P.A. et B. Watkinson. Visuoperceptual functioning differs in 9- to 12-year olds prenatally exposed to cigarettes and marihuana, Neurotoxicology and Teratology, vol. 22, 2000, p. 11–20. Fried, P.A., B. Watkinson et R. Gray. A follow-up study of attentional behaviour in 6-yearold children exposed prenatally to marihuana, cigarettes, and alcohol, Neurotoxicology and Teratology, vol. 14, 1992, p. 299–311. Fried, P.A., B. Watkinson et R. Gray. Differential effects on cognitive functioning in 9- to 12-year olds prenatally exposed to cigarettes and marihuana, Neurotoxicology and Teratology, vol. 20, 1998, p. 293–306. Fried, P.A., B. Watkinson et R. Gray. Differential effects on cognitive functioning in 13- to 16-year olds prenatally exposed to cigarettes and marihuana, Neurotoxicology and Teratology, vol. 25, 2003, p. 427–436. Fried, P.A., B. Watkinson et R. Gray. Neurocognitive consequences of marihuana: A comparison with pre-drug performance, Neurotoxicology and Teratology, vol. 27, 2005, p. 231–239. Fung, M., C. Gallagher et M. Machtay. Lung and aero-digestive cancer in young marijuana smokers, Tumori, vol. 85, 1999, p. 140–142. Goldschmidt, L., N.L. Day et G.A. Richardson. Effects of prenatal marijuana exposure on child behaviour problems at age 10, Neurotoxicology and Teratology, vol. 22, 2000, p. 325–336.

© Centre canadien de lutte contre l’alcoolisme et les toxicomanies | Janvier 2011

Page 4 de 10

Bibliographie sur le cannabis, Xperimentations.ca

Goldschmidt, L., G.A. Richardson, M.D. Cornelius et N.L. Day. Prenatal marijuana and alcohol exposure and academic achievement at age 10, Neurotoxicology and Teratology, vol. 26, 2004, p. 521–532. Goldschmidt, L., G.A. Richardson, J. Willford et N.L. Day. Prenatal marijuana exposure and intelligence test performance at age 6, Journal of the American Academy of Child and Adolescent Psychiatry, vol. 47, 2008, p. 254–263. Gong, H., S. Fligiel, D. Tashkin et R. Barbers. Tracheobronchial changes in habitual, heavy smokers of marijuana with and without tobacco, American Review of Respiratory Disease, vol. 136, 1987, p. 142–149. Grant, I., R. Gonzalez, C.L. Carey, L. Natarajan et T. Wolfson. Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study, Journal of the International Neuropsychological Society, vol. 9, 2003, p. 679–689. Gray, K.A., N.L. Day, S. Leech et G.A. Richardson. Prenatal marijuana exposure: Effect on child depressive symptoms at ten years of age, Neurotoxicology and Teratology, vol. 27, 2005, p. 439–448. Gruber, A.J. et H.G. Pope. Marijuana use among adolescents, Pediatric Clinics of North America, vol. 49, 2002, p. 389–413. Guzman, M. Cannabinoids: Potential anticancer agents, Nature Reviews Cancer, vol. 3, 2003, p. 745–755. Hall, W. et N. Solowij. The adverse health and psychological consequences of cannabis dependence. Dans R.A. Roffman et R.S. Stephens (éd.), Cannabis dependence: Its nature, consequences and treatment (p. 106–128), New York, Cambridge University Press, 2006. Hall, W., C. MacDonald et D. Currow. Cannabinoids and cancer: Causation, remediation and palliation, The Lancet Oncology, vol. 6, 2005, p. 35–42. Hall, W. The cannabis policy debate: Finding a way forward, Journal de l'Association médicale canadienne, vol. 162, 2000, p. 1690–1692. Hall, W. et N. Solowij. Adverse effects of cannabis, The Lancet, vol. 352, 1998, p. 1611– 1616. Hanson, K.L., J.L. Winward, A.D. Schweinsburg, K.L. Medina, S.A. Brown et S.F. Tapert. Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence, Addictive Behaviors, vol. 35, 2010, p. 970–976. Harder, V.S., A.R. Morral et J. Arkes. Marijuana use and depression among adults: Testing for causal associations, Addiction, vol. 101, 2006, p. 1463–1472.

© Centre canadien de lutte contre l’alcoolisme et les toxicomanies | Janvier 2011

Page 5 de 10

Bibliographie sur le cannabis, Xperimentations.ca

Hashibe, M., H. Morgenstern, Y. Cui et coll. Marijuana use and the risk of lung and upper aerodigestive tract cancers: Results of a population-based case-control study, Cancer Epidemiology, Biomarkers and Prevention, vol. 15, 2006, p. 1829–1834. Hayatbakhsh, M.R., J.M. Najman, K. Jamrozik, A.A. Mamun, R. Alati et W. Bor. Cannabis and anxiety and depression in young adults: A large prospective study, Journal of the American Academy of Child and Adolescent Psychiatry, vol. 46, 2007, p. 408–417. Henquet, C., L. Krabbendam, J. Spauwen, C. Kaplan, R. Lieb, H. Wittchen et coll. Prospective cohort study of cannabis use, predisposition for psychosis, and psychiatric symptoms in young people, British Medical Journal, vol. 330, 2005, p. 11. Henquet, C., L. Krabbendam, R. de Graaf, M. ten Have et J. van Os. Cannabis use and expression of mania in the general population, Journal of Affective Disorders, vol. 95, 2006, p. 103–110. Hoffmann, D., D. Brunnerman, G. Gori et E. Wynder. On the carcinogenicity of marijuana smoke, Recent Advances in Phytochemistry, vol. 9, 1975, p. 63–81. Horwood, L.J., D.M. Fergusson, M.R. Hayatbakhsh, J.M. Najman, C. Coffey, G.C. Patton, E. Silins et D.M. Hutchinson. Cannabis use and educational achievement: Findings from three Australian cohort studies, Journal of Drug and Alcohol Dependence, vol. 110, 2010, p. 247–253. Hsairi, M., N. Achour, B. Zouari et coll. Etiologic factors in primary bronchial carcinoma in Tunisia, La Tunisie Médicale, vol. 71, 1993, p. 265–268. Johns, A. Psychiatric effects of cannabis, British Journal of Psychiatry, vol. 178, 2001, p. 116–122. Kouri, E.M. et H.G. Pope. Abstinence symptoms during withdrawal from chronic marijuana use, Experimental and Clinical Psychopharmacology, vol. 8, 2000, p. 483–492. Leech, S.L., C.A. Larkby, R. Day et N.L. Day. Predictors and correlates of high levels of depression and anxiety symptoms among children at age 10, Journal of the American Academy of Child and Adolescent Psychiatry, vol. 45, 2006, p. 223–230. Leech, S.L., G.A. Richardson, L. Goldschmidt et N.L. Day. Prenatal substance exposure: Effects on attention and impulsivity of 6-year-olds, Neurotoxicology and Teratology, vol. 21, 1999, p. 109–118. Li, J.H. et L.F. Lin. Genetic toxicology of abused drugs: A brief review, Mutagenesis, vol. 13, 1998, p. 557–565.

© Centre canadien de lutte contre l’alcoolisme et les toxicomanies | Janvier 2011

Page 6 de 10

Bibliographie sur le cannabis, Xperimentations.ca

Lorenzetti, V., D.I. Lubman, S. Whittle, N. Solowij et M. Yucel. Structural MRI findings in long-term cannabis users: What do we know?, Substance Use and Misuse, vol. 45, 2010, p. 1787–1808. Lyketsos, C.G., E. Garrett, K.Y. Liang et J.C. Anthony. Cannabis use and cognitive decline in persons under 65 years of age, American Journal of Epidemiology, vol. 149, 1999, p. 794–800. Medina, K.L., K. Hanson, A.D. Schweinsburg, M. Cohen-Zion, B.J. Nagel et S.F. Tapert. Neuropsychological functioning in adolescent marijuana users: Subtle deficits detectable after a month of abstinence, Journal of the International Neuropsychological Society, vol. 13, 2007, p. 807–820. Mehra, R., B.A. Moore, K. Crothers, J. Tetrault et D.A. Fiellin. The association between marijuana smoking and lung cancer: A systematic review, Archives of Internal Medicine, vol. 166, 2006, p. 1359–1367. Mikulich, S.K., S.K. Hall, E.A. Whitmore et T.J. Crowley. Concordance between DSM-III-R and DSM-IV diagnoses of substance use disorders in adolescents, Drug and Alcohol Dependence, vol. 61, 2001, p. 237–248. Moore, T.H.M., S. Zammit, A. Lingford-Hughes, T.R.E. Barnes, P.B. Jones, M. Burke et coll. Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review, The Lancet, vol. 370, 2007, p. 319–328. Moskowitz, H. Marihuana and driving, Accident Analysis and Prevention, vol. 17, 1985, p. 323–345. Moskowitz, H., S. Hulbert et W. McGlothlin. Marijuana: Effects on simulated driving performance, Accident Analysis and Prevention, vol. 8, 1976, p. 45–50. Musty, R.E. et L. Kaback. Relationships between motivation and depression in chronic marijuana users, Life Sciences, vol. 56, 1995, p. 2151–2158. Noland, J.S., L.T. Singer, E.J. Short, S. Minnes, R.E. Arendt, H.L. Kirchner et coll. Prenatal drug exposure and selective attention in preschoolers, Neurotoxicology and Teratology, vol. 27, 2005, p. 429–438. Organisation mondiale de la Santé. Cannabis: A health perspective and research agenda (Report no. WHO/MSA/PSA/97.4), Genève (Suisse), Programme sur l’abus de substances, Département Santé mentale et abus de substances psychoactives, Oganisation mondiale de la Santé, 1997. Patton, G.C., C. Coffey, J.B. Carlin, L. Degenhardt, M. Lynskey et W. Hall. Cannabis use and mental health in young people: Cohort study, British Medical Journal, vol. 325, 2002, p. 1195–1198.

© Centre canadien de lutte contre l’alcoolisme et les toxicomanies | Janvier 2011

Page 7 de 10

Bibliographie sur le cannabis, Xperimentations.ca

Pope, H.G., A.J. Gruber, J.L. Hudson, M.A. Huestis et D. Yurgelun-Todd. Neuropsychological performance in long-term cannabis users, Archives of General Psychiatry, vol. 58, 2001, p. 909–915. Pope, H.G., A.J. Gruber, J.I. Hudson, M.A. Huestis et D. Yurgelun-Todd. Cognitive measures in long-term cannabis users, Journal of Clinical Pharmacology, vol. 42, 2002, p. 41S–47S. Pope, H.G., A.J. Gruber, J.I. Hudson, C. Cohane, M.A. Huestis et D. Yurgelun-Todd. Earlyonset cannabis use and cognitive deficits: What is the nature of the association?, Drug and Alcohol Dependence, vol. 69, 2003, p. 303–310. Pope, H.G. et D. Yurgelun-Todd. The residual cognitive effects of heavy marijuana use, Journal of the American Medical Association, vol. 275, 1996, p. 521–527. Porath, A.J. et P.A. Fried. Effects of prenatal cigarette and marijuana exposure on drug use among offspring, Neurotoxicology and Teratology, vol. 27, 2005, p. 267–277. Ranganathan, M. et D.C. D'Souza. The acute effects of cannabinoids on memory in humans: A review, Psychopharmacology, vol. 188, 2006, p. 425–444. Ramaekers, J.G., H.W.J. Robbe et J.F. O’Hanlon. Marijuana, alcohol and actual driving performance, Human Psychopharmacology: Clinical and Experimental, vol. 15, 2000, p. 551–558. Richardson, G.A., C. Ryan, J. Willford, N.L. Day et L. Goldschmidt. Prenatal alcohol and marijuana exposure: Effects on neuropsychological outcomes at 10 years, Neurotoxicology and Teratology, vol. 24, 2002, p. 309–320. Rickert, W., J. Robinson et B. Rogers. A comparison of tar, carbon monoxide and pH levels in smoke from marijuana and tobacco cigarettes, Revue canadienne de santé publique, vol. 73, 1982, p. 386–391. Robbe, H.W.J. et J.F. O’Hanlon. Marijuana, Alcohol and Actual Driving Performance (National Highway Traffic Safety Administration Final Report No. DOT-HS808939), Washington (DC), ministère américain des transports, 1999. Roy, P., F. Magnan-Lapoint, N. Huy et M. Boutet. Chronic inhalation of marijuana and tobacco in dogs, Research Communications in Chemical Pathology and Pharmacology, vol. 14, 1976, p. 305–317. Ryan, A.K. The lasting effects of marijuana use on educational attainment in midlife, Substance Use and Misuse, vol. 45, 2010, p. 554–597. Sasco, A., R. Merrill, I. Dari et coll. A case control study of lung cancer in Casablanca, Morocco, Cancer Causes and Control, vol. 13, 2002, p. 609–616.

© Centre canadien de lutte contre l’alcoolisme et les toxicomanies | Janvier 2011

Page 8 de 10

Bibliographie sur le cannabis, Xperimentations.ca

Schweinsburg, A.D., B.J. Nagel, B.C. Schweinsburg, A. Park, R.J. Theilmann et coll. Abstinent adolescent marijuana users show altered fMRI response during spatial working memory, Psychiatry Research: Neuroimaging, vol. 163, 2008, p. 40–51. Sidney, S., C.P. Quesenberry, G.D. Friedman et I.S. Tekawa. Marijuana use and cancer incidence (California, United States), Cancer Causes and Control, vol. 8, 1997, p. 722–728. Smith, A.M., P.A. Fried, M.J. Hogan et I. Cameron. Effects of prenatal marijuana on response inhibition: An fMRI study in young adults, Neurotoxicology and Teratology, vol. 26, 2004, p. 533–542. Smith, A.M., P.A. Fried, M.J. Hogan et I. Cameron. Effects of prenatal marijuana on visuospatial working memory: An fMRI study in young adults, Neurotoxicology and Teratology, vol. 28, 2006, p. 286–295. Sridhar, K., W. Raub, N. Weatherby et coll. Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age, Journal of Psychoactive Drugs, vol. 26, 1994, p. 285–288. Stahl, S.M. Essential psychopharmacology: Neuroscientific basis and practical applications (2nd ed.), Cambridge (R.-U.), Cambridge University Press, 2000. Stefanis, N.C., P. Delespaul, C. Henquet, C. Bakoula, C.N. Stefanis et J. van Os. Early adolescent cannabis exposure and negative dimensions of psychosis, Addiction, vol. 99, 2004, p. 1333–1341. Tan, W.C., C. Lo, A. Jong et coll. Marijuana and chronic obstructive lung disease: A population-based study, Journal de l'Association médicale canadienne, vol. 180, 2009, p. 814–820. Tashkin, D., G.C. Baldwin, T. Sarafian, S. Dubinett et M.D. Roth. Respiratory and immunologic consequences of marijuana smoking, Journal of Clinical Pharmacology, vol. 42, 2002, p. 71S–81S. Tashkin, D., F. Gliederer, J. Rose, P. Chang, K.K. Hui, Y. Jun Liang et coll. Tar, CO and THC delivery from the 1st and 2nd halves of a marijuana cigarette, Pharmacology, Biochemistry and Behaviour, vol. 40, 1991, p. 657–661. Taylor, F.M. III. Marijuana as a potential respiratory tract carcinogen: A retrospective analysis of a community hospital population, Southern Medical Journal, vol. 81, 1988, p. 1213–1216. Thomson, W.M., R. Poulton, J.M. Broadbent, T.E. Moffitt, A. Caspi, J.D. Beck et coll. Cannabis smoking and periodontal disease among young adults, Journal of the American Medical Association, vol. 299(5), 2008, p. 525–531.

© Centre canadien de lutte contre l’alcoolisme et les toxicomanies | Janvier 2011

Page 9 de 10

Bibliographie sur le cannabis, Xperimentations.ca

van Laar, M., S. van Dorsselaer, K. Monshouwer et R. de Graaf. Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population?, Addiction, vol. 102, 2007, p. 1251–1260. van Os, J., M. Bak, M. Hanssen, R.V. Bijl, R. de Graaf et H. Verdoux. Cannabis use and psychosis: A longitudinal population-based study, American Journal of Epidemiology, vol. 156, 2002, p. 319–327. Vandrey, R.G., A.J. Budney, J.L. Kamon et C. Stanger. Cannabis withdrawal in adolescent treatment seekers, Drug and Alcohol Dependence, vol. 78, 2005, p. 205–210. Viveros, M.P., R. Llorente, E. Moreno et E.M. Marco. Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods, Behavioural Pharmacology, vol. 16, 2005, p. 353–362. Voirin, N., J. Berthiller, V. Benhaim-Luzon et coll. Risk of lung cancer and past use of cannabis in Tunisia, Journal of Thoracic Oncology, vol. 1, 2006, p. 577–579. Wilson, W., R. Matthew, T. Turkington, T. Hawk, R.E. Coleman et J. Provenzale. Brain morphological changes and early marijuana use: A magnetic resonance and positron emission tomography study, Journal of Addictive Diseases, vol. 19, 2000, p. 1–22. Wu, T., D. Tashkin, B. Djahed et J. Rose. Pulmonary hazards of smoking marijuana as compared with tobacco, New England Journal of Medicine, vol. 318, 1988, p. 347– 351. Yucel, M., N. Solowij, C. Respondek, S. Whittle, A. Fornito, C. Pantelis et coll. Regional brain abnormalities associated with long-term heavy cannabis use, Archives of General Psychiatry, vol. 65, 2008, p. 694–701. Zammit, S. An investigation into the use of cannabis and tobacco as risk factors for schizophrenia (thèse de doctorat, Université Cardiff), 2004. Zhu, L., S. Sharma, M. Stolina et coll. Delta-9-tetrahydrocannabinol inhibits antitumour immunity by a CB2 receptor-mediated, cytokine dependent pathway, Journal of Immunology, vol. 165, 2000, p. 373–380.

Centre canadien de lutte contre l’alcoolisme et les toxicomanies 75, rue Albert, bureau 500 | Ottawa (Ontario) K1P 5E7 | Canada Tél. : 613-235-4048 | Téléc. : 613-235-8101 | [email protected]

© Centre canadien de lutte contre l’alcoolisme et les toxicomanies | Janvier 2011

Page 10 de 10

Suggest Documents